Literature DB >> 11853176

Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis.

Masaki Baba1, Ryoya Asano, Ikumi Takigami, Tetsuyuki Takahashi, Masayoshi Ohmura, Yoshihito Okada, Hajime Sugimoto, Tadashi Arika, Hoyoku Nishino, Toru Okuyama.   

Abstract

Isoliquiritigenin is a natural pigment with the simple chalcone structure, 4,2',4'-trihydroxychalcone. The effect of this compound on azoxymethane (AOM)-induced colonic aberrant crypt focus and tumor formation in ddY mice was examined. Administration of 15 ppm of isoliquiritigenin in drinking water, significantly suppressed AOM-induced aberrant crypt focus formation (p<0.01), with an inhibitory ratio of 37.3%. Isoliquiritigenin also inhibited AOM-induced colon carcinogenesis by administration in a mixed diet. The average number of tumors was 14.6+/-8.9 items in the control group and were 7.3+/-7.3, 3.9+/-5.6, 4.7+/-6.5 items in the 10, 100 and 250 ppm in the isoliquiritigenin treated groups, respectively. In histopathological studies, the tumors were identified as adenoma and adenocarcinoma, however, significant differences were not observed between the control group and isoliquiritigenin treated groups. These results indicated that isoliquiritigenin might be a potential chemopreventive agent against colon cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853176     DOI: 10.1248/bpb.25.247

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  17 in total

1.  Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells.

Authors:  Tatsushi Yoshida; Mano Horinaka; Mami Takara; Mayuko Tsuchihashi; Nobuhiro Mukai; Miki Wakada; Toshiyuki Sakai
Journal:  Environ Health Prev Med       Date:  2008-07-31       Impact factor: 3.674

Review 2.  Quinone reductase induction as a biomarker for cancer chemoprevention.

Authors:  Muriel Cuendet; Carol P Oteham; Richard C Moon; John M Pezzuto
Journal:  J Nat Prod       Date:  2006-03       Impact factor: 4.050

3.  Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.

Authors:  Balasubramanian Srinivasan; Thomas E Johnson; Chengguo Xing
Journal:  Bioorg Med Chem Lett       Date:  2010-10-20       Impact factor: 2.823

4.  Sites of alkylation of human Keap1 by natural chemoprevention agents.

Authors:  Yan Luo; Aimee L Eggler; Dongting Liu; Guowen Liu; Andrew D Mesecar; Richard B van Breemen
Journal:  J Am Soc Mass Spectrom       Date:  2007-10-02       Impact factor: 3.109

5.  Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice.

Authors:  Muriel Cuendet; Jian Guo; Yan Luo; Shaonong Chen; Carol P Oteham; Richard C Moon; Richard B van Breemen; Laura E Marler; John M Pezzuto
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-12

6.  Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases.

Authors:  Jian Guo; Ang Liu; Hongmei Cao; Yan Luo; John M Pezzuto; Richard B van Breemen
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

7.  Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.

Authors:  Xuesen Li; Xia Xu; Tao Ji; Zhongbo Liu; Mai Gu; Bang H Hoang; Xiaolin Zi
Journal:  Toxicol Rep       Date:  2014

8.  An update on antitumor activity of naturally occurring chalcones.

Authors:  En-Hui Zhang; Ru-Feng Wang; Shu-Zhen Guo; Bin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

9.  Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine.

Authors:  Halmurat Upur; Abdiryim Yusup; Isabelle Baudrimont; Anwar Umar; Benedicte Berke; Dilxat Yimit; Jaya Conser Lapham; Edmon E Creppy; Nicholas Moore
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

10.  Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation.

Authors:  Neng Wang; Zhiyu Wang; Yu Wang; Xiaoming Xie; Jiangang Shen; Cheng Peng; Jieshu You; Fu Peng; Hailin Tang; Xinyuan Guan; Jianping Chen
Journal:  Oncotarget       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.